Trump's pharma tariff raises global concerns, Indian generics safe
after close1 source ↓written by the desknot a recommendation
- on select pharmaceutical
- 100% tariff
US President Donald Trump announced a 100% tariff on select pharmaceutical imports, escalating trade tensions. Jefferies reported that Indian generic drug makers are likely to remain exempt from tariffs, mitigating potential impacts on the sector. The move raises concerns over drug shortages and pricing pressures globally.
Not investment advice. For informational purposes only.